On September 4, 2019 Accuray Incorporated (NASDAQ: ARAY) reported that the Company will host an Investor Meeting during the American Society of Radiation Oncology (ASTRO) Annual Meeting, being held in Chicago, IL (Press release, Accuray, SEP 4, 2019, View Source [SID1234539291]). The presentations will commence at 3:00pm CT (4:00pm ET/1:00pm PT) and will conclude at 5:30pm CT (6:30pm ET/3:30pm PT).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The program will include presentations by Accuray’s senior management team and clinical key opinion leaders about the Company’s solutions for addressing today’s cancer challenges and will also include question and answer sessions. The topics being discussed include: Solutions for Today’s Market, the Radixact System and the advanced Synchrony Motion Tracking and Correction Technology1, the CyberKnife System and CyberKnife VOLO Optimizer Technology, and U.S. Reimbursement Developments.

Due to the limited space, guests must register to attend Accuray’s ASTRO investor meeting. Please RSVP to Michael Polyviou at [email protected] by Monday, September 9, 2019.

For those not attending the ASTRO meeting, a webcast will be available on the Investor Relations page of the Company’s website at View Source A replay of the webcast will also be available on the Company’s website following the event.